figshare
Browse
Fig_3.tif (1.78 MB)

The percentage of Treg (CD4+CD25+ Foxp3+), Th17 (CD4+IL-17+) cells in representative patients with ND, CR, relapsed-refractory AML patients or in controls.

Download (0 kB)
figure
posted on 2015-07-02, 04:23 authored by Tian Tian, Shuang Yu, Lu Liu, Fuzhong Xue, Cunzhong Yuan, Min Wang, Chunyan Ji, Daoxin Ma

A. Lymphocytes were gated by flow cytometry. B. The percentage of CD4+ lymphocytes. C, D, E, F. The percentage of Treg (CD4+CD25+ Foxp3+) cells in AML patients and controls. H, I, J, K. The percentage of Th17 (CD4+IL-17+) cells in AML patients and controls.

History

Usage metrics

    PLOS ONE

    Categories

    Keywords

    Acute Myeloid Leukemia PatientsT Helper Subsets15 controlsRORC expressionTreg cellschemotherapy amelioratedvariations.ConclusionTh subsetsleukemic blastSlight iron deficiency anemia patientsbone marrowNegative correlationflow cytometryVariations BackgroundT helperAML leukemic blast cells.MethodsBMilbone marrow microenvironmentTh subsets frequencieselisaTh subsetsDifferent StageswbcND patientstranscription factor Foxp 3Myeloid leukemiaCR patientstranscription factorTh 1Th 2Recurrent Th abnormalitiesAML pathogenesis

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC